Nuvectis Pharma, Inc. (NVCT)
23.92
+0.86
(+3.73%)
USD |
NASDAQ |
Sep 02, 16:00
24.00
+0.08
(+0.33%)
After-Hours: 20:00
Nuvectis Pharma Net Income (TTM) : -30.28M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -30.28M |
| March 31, 2026 | -29.59M |
| December 31, 2025 | -28.87M |
| September 30, 2025 | -27.80M |
| June 30, 2025 | -22.07M |
| March 31, 2025 | -20.16M |
| December 31, 2024 | -19.00M |
| September 30, 2024 | -19.37M |
| June 30, 2024 | -21.10M |
| March 31, 2024 | -22.38M |
| Date | Value |
|---|---|
| December 31, 2023 | -22.26M |
| September 30, 2023 | -22.33M |
| June 30, 2023 | -22.33M |
| March 31, 2023 | -20.19M |
| December 31, 2022 | -19.08M |
| September 30, 2022 | -14.65M |
| June 30, 2022 | -13.44M |
| March 31, 2022 | -15.81M |
| December 31, 2021 | -12.89M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Decoy Therapeutics, Inc. | -14.45M |
| Unicycive Therapeutics, Inc. | -35.22M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |